{"article_link": "https://doi.org/10.1038/s41467-024-47463-6", "data": [{"id": "data_1", "omics": "Transcriptomics (RNA-seq)", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842", "format": "FASTQ", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE228842", "notes": "Includes next-gen RNA-seq data (short-read)."}, {"id": "data_2", "omics": "Transcriptomics (miRNA)", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842", "format": "FASTQ", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE228842", "notes": "Part of the same GEO deposition as data_1."}, {"id": "data_3", "omics": "Transcriptomics (sRNA)", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228842", "format": "FASTQ", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE228842", "notes": "Part of the same GEO deposition as data_1."}, {"id": "data_4", "omics": "Proteomics (Serum Cytokines)", "link": "", "format": "", "source": "Custom Luminex and MSD assays", "public_id": "", "notes": "Measured via Luminex (20-plex panel) and MSD (V-PLEX Human Proinflammatory Panel 1 kit). Data not publicly available."}], "analyses": [{"id": "analysis_1", "analysis_type": "Differential gene expression analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"], "infection_status": ["NAAT+ve", "NAAT-ve"], "time_point": ["D0", "CT", "CT + 7"]}}, {"id": "analysis_2", "analysis_type": "Gene set enrichment analysis (GSEA)", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_3", "analysis_type": "Principal Component Analysis (PCA)", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_4", "analysis_type": "Blood transcriptional module (BTM) analysis", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_5", "analysis_type": "Differential cytokine analysis", "analysis_data": ["data_4"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_6", "analysis_type": "CIBERSORTx deconvolution", "analysis_data": ["data_1"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_7", "analysis_type": "miRNA set enrichment analysis", "analysis_data": ["data_2"], "label": {"comparison": "miRNA enrichment in ChAdOx1 nCoV-19 vs. Placebo at CT", "pathway": ["response to TNF-alpha", "interferon-gamma-mediated signaling pathway"]}}, {"id": "analysis_8", "analysis_type": "Differential sRNA expression analysis", "analysis_data": ["data_3"], "label": {"vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}, {"id": "analysis_9", "analysis_type": "Temporal miRNA expression analysis", "analysis_data": ["data_3"], "label": {"time_point": ["CT", "CT + 7"]}}, {"id": "analysis_10", "analysis_type": "miRNA-mRNA integration analysis", "analysis_data": ["data_1", "data_2"], "label": {"hypothesis": "Downregulation of miRNAs promotes pro-inflammatory mRNA pathways", "pathway": ["response to TNF-alpha", "interferon-gamma-mediated signaling pathway"]}}, {"id": "analysis_11", "analysis_type": "Differential transcript isoform analysis (3rd-gen RNA-seq)", "analysis_data": ["data_1"], "label": {"isoform": "MX1-201", "vaccine_group": ["ChAdOx1 nCoV-19", "Placebo"]}}], "results": [{"analysis_id": "analysis_1", "metric": "number_of_DEGs", "value": {"Placebo vs. Baseline": "684", "ChAdOx1 nCoV-19 vs. Placebo": "5", "NAAT+ve vs. NAAT-ve": "1119"}, "features": ["MX1-201 isoform", "KREMEN1"], "label": {"condition": "Differential gene expression across conditions"}}, {"analysis_id": "analysis_2", "metric": "p_value", "value": {"response_to_virus": "0.01", "type_I_interferon": "0.01"}, "features": ["response to virus", "type I interferon"], "label": {"condition": "GSEA in ChAdOx1 nCoV-19 vs. Placebo"}}, {"analysis_id": "analysis_5", "metric": "fold_change", "value": "Higher in NAAT+ve placebo group", "features": ["IP10", "IL10", "MCP1"], "label": {"condition": "Cytokine levels in NAAT+ve groups"}}, {"analysis_id": "analysis_6", "metric": "cell_abundance_difference", "value": "Lower neutrophil abundance in placebo group", "features": ["neutrophils"], "label": {"condition": "CIBERSORTx deconvolution results"}}, {"analysis_id": "analysis_7", "metric": "p_value", "value": {"response_to_TNF_alpha": "0.01", "interferon_gamma_mediated_signaling_pathway": "0.01"}, "features": ["response to TNF-alpha", "interferon-gamma-mediated signaling pathway"], "label": {"condition": "miRNA enrichment in ChAdOx1 nCoV-19 vs. Placebo"}}, {"analysis_id": "analysis_8", "metric": "description", "value": "Delayed increase in placebo group", "features": ["snoRNA-derived sRNA"], "label": {"condition": "sRNA dynamics over time"}}, {"analysis_id": "analysis_9", "metric": "description", "value": "Global miRNA downregulation at CT; recovery by CT + 7", "features": ["miRNA repression", "mRNA upregulation"], "label": {"condition": "Temporal miRNA expression"}}, {"analysis_id": "analysis_10", "metric": "description", "value": "Global miRNA repression leads to mRNA upregulation in pro-inflammatory pathways", "features": ["response to TNF-alpha", "interferon-gamma-mediated signaling pathway"], "label": {"condition": "miRNA-mRNA integration"}}, {"analysis_id": "analysis_11", "metric": "fold_change", "value": "Upregulated in placebo group at CT (fdr = 0.00345 vs. baseline; fdr = 0.018 vs. ChAdOx1 nCoV-19)", "features": ["MX1-201 isoform"], "label": {"condition": "MX1-201 isoform expression in ChAdOx1 nCoV-19 vs. Placebo"}}]}